Technically, they're GLP-1 receptor agonists, because they work on the same cell receptors as GLP-1 to activate the same response slowing digestion, prompting insulin release, and limiting appetite
In der medizinischen Forschung wird es jedoch als biologisch aktives Peptid untersucht, das in regenerative Prozesse eingreift
In cell experiments, GLP-1 was found to have more mechanisms that may inhibit liver fat synthesis, such as FAM3A, NRF2, NaB, SHP1/AMPK, NLRP3, FGF21, IRS2, and other signaling pathways, which also provided direct evidence for the role of GLP-1R in the regulation of lipid metabolism in the liver
5- Adjuvant in patients taking anticonvulsant drugs , as these drugs increase excretion of carnitine
Completion rates ranged from 22.9% to 60.8%, with an average of 42.4%